Michael Volpe
About Michael Volpe
Michael Volpe is an SEC Reporting Analyst at Supernus Pharmaceuticals, Inc., where he has worked since 2023. He has a background in accounting and finance, having previously held positions at EY and completed an internship at Perspecta.
Current Role at Supernus Pharmaceuticals
Michael Volpe serves as an SEC Reporting Analyst at Supernus Pharmaceuticals, Inc. since 2023. In this role, he focuses on the development of SEC filings and financial reporting processes. His responsibilities include ensuring compliance with financial regulations and enhancing the accuracy of financial reports. He collaborates with various departments to improve reporting efficiency.
Previous Experience at EY
Prior to his current position, Michael Volpe worked at EY as Assurance Staff from 2020 to 2023. In this capacity, he was involved in auditing and assurance services, contributing to the accuracy of financial statements for clients. He also completed an internship at EY in 2019, where he gained foundational experience in assurance practices.
Internship Experience at Perspecta
Michael Volpe completed a three-month internship as an Accounting Intern at Perspecta in 2018. This experience provided him with practical exposure to accounting processes and financial reporting while working in Herndon, Virginia.
Education in Accounting and Finance
Michael Volpe earned a Bachelor's degree in Accounting and Finance from Longwood University, where he studied from 2016 to 2020. His academic background has equipped him with the necessary skills and knowledge to excel in financial reporting and accounting roles.
Contributions to Financial Reporting
At Supernus Pharmaceuticals, Michael Volpe has contributed to the implementation of new accounting standards and compliance measures. His work focuses on enhancing the overall financial reporting processes, ensuring that the company adheres to industry regulations and standards.